Prabhakar Boddu

Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative Colitis

Gary R. Lichtenstein, Michael A. Kamm, Prabhakar Boddu et al. · Clinical Gastroenterology and Hepatology · 2007 · 265 citations

Inflammation, Chronic Inflammatory Diseases, Twice-daily Mmx Mesalamine +5

Etiology and mode of presentation of chronic liver diseases in India: A multi centric study

Partha Sarathi Mukherjee, Vishnubhatla Sreenivas, Deepak Amarapurkar et al. · PLoS ONE · 2017 · 130 citations · Full text

Gastroenterology, Pathology, Hepatitis B +27

Dna Methylation in Esophageal Diseases Including Cancer: Special Reference to hMLH1 Gene Promoter Status

Vasavi Mohan, Shivani Ponnala, Kusumanjali Gujjari et al. · Tumori Journal · 2006 · 30 citations

Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis.

Philip Abraham, Jude Rodriques, Nivedita Moulick et al. · PubMed · 2013 · 27 citations

Acute Pancreatitis, Severe Acute Pancreatitis, New Organ Dysfunction +11

Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial

K T Shenoy, Leena Kondarappassery Balakumaran, Philip Mathew et al. · Journal of Clinical and Experimental Hepatology · 2014 · 23 citations · Full text

Metabolic Associated Steatohepatitis, Metadoxine Versus Placebo, Hepatology +7